Hong-Lin He
Overview
Explore the profile of Hong-Lin He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He H, Lai H, Chan T, Hsing C, Huang S, Hsieh K, et al.
World J Surg Oncol
. 2023 Feb;
21(1):62.
PMID: 36841776
Background: With the advance in genome-wide analyses, genetic alternations have been found to play an important role in carcinogenesis and aggressiveness of UC. Through bioinformatic analysis of gene expression profiles...
2.
Chou C, Chen T, Li W, Lee S, Yang C, Tian Y, et al.
Onco Targets Ther
. 2022 Oct;
15:1171-1181.
PMID: 36238133
Purpose: For locally advanced rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) allows tumor downstaging and makes curative radical proctectomy possible. However, we lack a genetic biomarker to predict cancer prognosis or...
3.
Yu G, Zhagn L, He H, Yang M
Ying Yong Sheng Tai Xue Bao
. 2021 Oct;
32(8):2653-2665.
PMID: 34664437
More attention has been paid to the monitoring, assessment, prediction, early warning and sustainable management of regional ecological environment and the changes of ecosystem state in recent years. It is...
4.
Prognostic significance of in urothelial carcinoma: low expression is associated with worse survival
Lai C, Chen T, Chan T, Li W, He H
Future Oncol
. 2021 Sep;
17(31):4145-4156.
PMID: 34467778
Bioinformatic analysis has revealed that is significantly downregulated in muscle-invasive bladder cancer. The expression of OXR1 in patients with urothelial carcinoma was evaluated by immunohistochemistry, including 340 cases with urothelial...
5.
Chen T, Dehghanian S, Chan T, He H, Li W, Abdollahi S, et al.
Med Mol Morphol
. 2021 Aug;
54(4):356-367.
PMID: 34398348
Data mining on a public domain detected eight potential transcripts which were upregulated in advanced UBUCs, suggesting that they may take part in UC development or/and progression. Retrospectively, immunohistochemistry along...
6.
Chen T, Chan T, Li C, Dissanayaka D, Kianpour M, He H, et al.
Int J Urol
. 2021 Aug;
28(11):1178-1187.
PMID: 34374132
Objective: To examine the expression levels of the glycosyltransferase 8 domain containing protein 2 and its clinical implications in urothelial carcinoma patients. Methods: Data mining, immunohistochemistry together with H-score calculation...
7.
Wang J, Zhao X, Ye H, Zhang Z, He H
Ying Yong Sheng Tai Xue Bao
. 2021 Jul;
32(6):2119-2128.
PMID: 34212618
Evapotranspiration (ET) is a fundamental flux in land surface hydrothermal process. Because of the differences in basic concepts, assumptions, application scales, different models have induced varying uncertainties to the estimation...
8.
Chen T, Tian Y, Chou C, Chan T, He H, Li W, et al.
Curr Oncol
. 2021 Jul;
28(4):2373-2384.
PMID: 34202399
Background: Patients with rectal cancer can prospectively be favored for neoadjuvant concurrent chemoradiotherapy (CCRT) to downstage before a radical proctectomy, but the risk stratification and clinical outcomes remain disappointing. Methods:...
9.
Chen T, Chou C, Tian Y, Yeh C, Chan T, He H, et al.
Int J Clin Oncol
. 2021 May;
26(9):1689-1697.
PMID: 34043102
Background: Rectal cancer patients can conceivably obtain relief from neoadjuvant concurrent chemoradiotherapy (CCRT) for downstaging before resection, but the stratification of risk and clinical outcomes remains challenging. Therefore, identifying effective...
10.
Hsiao S, He H, Weng T, Lin C, Chao C, Huang W, et al.
Case Rep Oncol
. 2021 Mar;
14(1):232-238.
PMID: 33776709
Anti-epithelial growth factor receptor or anti-vascular endothelial growth factor agents combined with chemotherapy were the standard of treatment for metastatic colorectal cancer (CRC). However, increasing evidence of molecularly stratified treatment...